Oxipital AI
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- Undisclosed
Investors
- 3
About Oxipital AI
Oxipital AI is a US-based company specializing in advanced AI machine vision systems. Its flagship product, the V-CORTX platform, enhances operational efficiency in manufacturing through real-time quality control and data insights. Founded in 2024 in Bedford, US, Oxipital AI focuses on integrating AI vision technology for manufacturers and machine builders. Mark Chiappetta serves as the CEO of the company. Oxipital AI specializes in advanced AI machine vision systems, primarily through its flagship product, the V-CORTX platform. This integrated AI vision platform empowers manufacturers and machine builders to implement and scale machine vision technology efficiently, addressing critical challenges in high-variability manufacturing environments. V-CORTX enables real-time product inspections and quality control, significantly enhancing operational efficiency and decision-making processes across various manufacturing sectors, particularly in the food industry. The platform utilizes a user-friendly web-based interface that allows clients to gain actionable insights through live dashboards, facilitating rapid deployment without the need for coding or extensive training data preparation.Oxipital AI generates revenue through a business-to-business (B2B) model, primarily offering subscription-based access to its V-CORTX platform along with associated support services. The revenue structure includes partnerships with large-scale manufacturers who integrate the V-CORTX solution into their production lines for quality inspection and robotic guidance. Clients typically engage in transactions that involve annual licensing fees for software access, alongside potential costs for hardware like specialized cameras designed for food-grade environments. Specific pricing details for individual services and solutions are tailored to meet the needs of clients, often reflecting the scale and complexity of the deployment. The company’s revenue is further bolstered by the sale of custom solutions and ongoing maintenance services that ensure optimal system performance. The company has plans for expanding its V-CORTX offerings and targeting new markets, particularly in North America and Europe, to increase its footprint in the manufacturing sector.
Who invested in Oxipital AI
3 investors across 1 round
See all investors in Oxipital AI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 8, 2026
Amount
Undisclosed
Investors
Questions about Oxipital AI
Who invested in Oxipital AI?
Oxipital AI has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oxipital AI raised?
Oxipital AI has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oxipital AI last raise money?
Oxipital AI's most recent round on record is a Series A, in Jul 2026.
What does Oxipital AI do?
Oxipital AI is a US-based company specializing in advanced AI machine vision systems.
Where is Oxipital AI headquartered?
Oxipital AI is headquartered in Bedford, US.
Which VCs invest in companies like Oxipital AI?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back industrial machinery companies at Oxipital AI's stage. Their profiles are linked below.
VCs backing industrial machinery startups at Series A
Raising like Oxipital AI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.